Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

BioNexus Gene Lab Corp

BGLC:NAQ

BioNexus Gene Lab Corp

Actions
Basic MaterialsIndustrial Materials
  • Price (USD)0.4398
  • Today's Change0.036 / 8.92%
  • Shares traded65.56k
  • 1 Year change-53.21%
  • Beta1.8403
Data delayed at least 15 minutes, as of Sep 23 2024 15:20 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, BioNexus Gene Lab Corp (BGLC:NAQ) traded at 0.4398, 41.87% above the 52 week low of 0.31 set on Nov 15, 2023.
52-week range
Today
0.31Nov 15 20233.39Feb 13 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.421
High0.4398
Low0.415
Bid0.415
Offer0.4268
Previous close0.4038
Average volume2.24m
Shares outstanding17.97m
Free float6.89m
P/E (TTM)--
Market cap7.26m USD
EPS (TTM)-0.1108
USD
Data delayed at least 15 minutes, as of Sep 23 2024 15:20 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.